ALGERT GLOBAL LLC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1275218 SAN FRANCISCO, CA

Position in CGEM

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$671,056

-$888,221 QoQ

Shares Held

36,851

-66.4% QoQ

Ownership

0.057%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#84

of 183 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names. CGEM ranks #86 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PCVX	Vaxcyte, Inc.	515,343	$29,956,888
2	ROIV	Roivant Sciences Ltd.	845,118	$29,908,726
3	XENE	Xenon Pharmaceuticals Inc.	419,773	$25,337,498
4	CLDX	Celldex Therapeutics, Inc.	647,836	$24,105,977
5	AXSM	Axsome Therapeutics, Inc.	95,335	$23,335,147
6	SNDX	Syndax Pharmaceuticals Inc	1,051,465	$22,985,024
7	MRNA	Moderna, Inc.	274,820	$19,245,644
8	MLYS	Mineralys Therapeutics, Inc.	649,027	$17,510,748

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$671,056	36,851	-66.4%	Shares	Sole	2026-08-13
2026-03-31	$1,559,277	109,731	-32.5%	Shares	Sole	2026-05-14
2025-12-31	$1,681,885	162,501	-31.2%	Shares	Sole	2026-02-17
2025-09-30	$1,400,025	236,092	+9.5%	Shares	Sole	2025-11-14
2025-06-30	$1,623,317	215,580	-2.6%	Shares	Sole	2025-08-14
2025-03-31	$1,676,225	221,430	+411.5%	Shares	Sole	2025-05-13
2024-12-31	$527,296	43,292	+8.5%	Shares	Sole	2025-02-14
2024-09-30	$667,658	39,884	0.0%	Shares	Sole	2024-11-12
2024-06-30	$695,576	39,884	-49.9%	Shares	Sole	2024-08-15
2024-03-31	$1,357,747	79,680	+94.2%	Shares	Sole	2024-05-15
2023-12-31	$417,993	41,020	+148.0%	Shares	Sole	2024-02-14
2023-09-30	$149,687	16,540	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.